bioAffinity Technologies (BIAF) News Today → Biden FINISHED On June 13th? (From Paradigm Press) (Ad) Free BIAF Stock Alerts $2.45 +0.57 (+30.32%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 10:32 PM | msn.comBIAF Stock Earnings: bioAffinity Technologies Reported Results for Q1 2024May 15 at 9:15 AM | businesswire.combioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory VolumesMay 2, 2024 | businesswire.combioAffinity Technologies News UpdateApril 26, 2024 | investing.combioAffinity Technologies appoints VP to enhance diagnosticsApril 24, 2024 | businesswire.combioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of GrowthApril 9, 2024 | finance.yahoo.combioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer ScreeningApril 9, 2024 | businesswire.combioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer ScreeningMarch 8, 2024 | finance.yahoo.combioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementMarch 8, 2024 | finance.yahoo.comWallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private PlacementMarch 6, 2024 | msn.comNasdaq Gains 100 Points; Campbell Soup Earnings Top ViewsMarch 6, 2024 | marketwatch.comBioAffinity Technologies Shares Plummet After Stock SaleMarch 6, 2024 | msn.comWhy BioAffinity Technologies (BIAF) Shares Are Down 50%March 6, 2024 | msn.comBioAffinity Technologies to raise $2.5M from stock offering and private placementMarch 6, 2024 | finance.yahoo.comWallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private PlacementMarch 6, 2024 | marketbeat.comTrading was temporarily halted for "BIAF" at 09:03 AM with a stated reason of "LULD pause."March 6, 2024 | marketbeat.comTrading was temporarily halted for "BIAF" at 09:03 AM with a stated reason of "LULD pause."March 6, 2024 | businesswire.combioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementMarch 6, 2024 | marketbeat.comTrading was temporarily halted for "BIAF" at 09:03 AM with a stated reason of "LULD pause."March 5, 2024 | marketbeat.comTrading was temporarily halted for "BIAF" at 09:03 AM with a stated reason of "LULD pause."March 1, 2024 | finance.yahoo.comHere's Why We're A Bit Worried About bioAffinity Technologies' (NASDAQ:BIAF) Cash Burn SituationFebruary 21, 2024 | finance.yahoo.combioAffinity Technologies News UpdateFebruary 21, 2024 | businesswire.combioAffinity Technologies News UpdateFebruary 6, 2024 | finance.yahoo.comMedical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical PracticeJanuary 23, 2024 | finance.yahoo.combioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of CancerJanuary 8, 2024 | finance.yahoo.combioAffinity Technologies In the NewsNovember 30, 2023 | marketwatch.comBioAffinity Shares Rise on Addition to Government Pay ScheduleNovember 30, 2023 | finance.yahoo.comCMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024November 15, 2023 | finance.yahoo.combioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer ScreeningNovember 14, 2023 | finance.yahoo.combioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business UpdateNovember 6, 2023 | bizjournals.comSA biotech hire to bolster national expansionNovember 6, 2023 | finance.yahoo.combioAffinity Technologies Names Dallas J. Coleman as National Director of SalesSeptember 7, 2023 | finance.yahoo.combioAffinity Technologies to Participate in the H.C. Wainwright Global Investment ConferenceAugust 16, 2023 | finance.yahoo.combioAffinity Technologies Second Quarter 2023 Earnings: US$0.20 loss per share (vs US$0.033 loss in 2Q 2022)August 11, 2023 | thestreet.comBioaffinity Technologies Inc ComMay 15, 2023 | bizjournals.comSA cancer detection biotech entering critical periodMay 15, 2023 | finance.yahoo.combioAffinity Technologies Reports First Quarter 2023 Financial ResultsMay 5, 2023 | fortune.comHow the workforce of the future will be more like an ‘ecosystem’May 1, 2023 | finance.yahoo.combioAffinity Technologies Names Michael Dougherty as Chief Financial OfficerApril 25, 2023 | finance.yahoo.combioAffinity Technologies Presents at Cleveland Clinic Lung Cancer SymposiumApril 5, 2023 | finance.yahoo.combioAffinity Technologies to Ring Nasdaq Closing Bell TodayApril 2, 2023 | seekingalpha.combioAffinity Technologies GAAP EPS of -$1.81, revenue of $2,500March 31, 2023 | finance.yahoo.combioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial ResultsJanuary 24, 2023 | msn.comU.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.31%January 24, 2023 | seekingalpha.comBIAF bioAffinity Technologies, Inc.January 24, 2023 | finance.yahoo.combioAffinity Technologies Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory ResearchJanuary 4, 2023 | finance.yahoo.combioAffinity Technologies Announces Notice to Award U.S. Patent Protecting Novel Compounds for Specific Delivery of Cancer TreatmentsJanuary 3, 2023 | marketbeat.comTrading was temporarily halted for "BIAF" at 09:01 AM with a stated reason of "LULD pause."December 19, 2022 | finance.yahoo.comArgus Research Initiates Equity Research Report Coverage on bioAffinity Technologies, Inc. (NasdaqCM: BIAF)December 15, 2022 | finance.yahoo.combioAffinity Technologies Expands Diagnostic Division with Promotions and New Hires to Strengthen Clinical BenchNovember 8, 2022 | finance.yahoo.combioAffinity Technologies to Report Third Quarter 2022 Financial Results Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAF and its competitors with MarketBeat's FREE daily newsletter. Email Address What’s Really Next for America… (Ad)Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly. Click here to stream this controversial exposé now. BIAF Media Mentions By Week BIAF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIAF News Sentiment▼0.300.55▲Average Medical News Sentiment BIAF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIAF Articles This Week▼50▲BIAF Articles Average Week Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Data Knights Acquisition News Today Exagen News Today Lumos Pharma News Today PolyPid News Today Nephros News Today Qilian International Holding Group News Today Lisata Therapeutics News Today Ekso Bionics News Today OncoCyte News Today Brainstorm Cell Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIAF) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsHow Biden has already won 2024Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityGold Set to EXPLODE!Gold Safe ExchangeBiden FINISHED On June 13th?Paradigm PressThe 1,000X Crypto PlaybookTrue Market InsidersWhy Is Gold On a MASSIVE rally? Huge AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.